24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
How to Make Your Child's Hospital Stay Safer, Less StressfulObesity May Boost Odds for MS in KidsHealth Tip: Diarrhea in KidsOpioid Epidemic Doubled Number of U.S. Kids Sent to Foster CareSwimming Lessons a Must for EveryoneHow to Help When Your Child Weighs Too MuchHave Kids, Buy More Produce?Zika's Damage Continues in Children Infected Before BirthCDC Warns of Start to 'Season' for Mysterious Paralyzing Illness in KidsParent Who Listens Can Help Kids Thrive Despite TraumaHealth Tip: Ear Piercing For KidsReacting Against a 'Too Clean' World, Some Parents Go Too Far the Other WaySurvey Urges Grandparents to Lock Down Their Meds When Kids VisitCalifornia Took on Anti-Vaxxers, and WonHow Does Sunshine During Pregnancy Affect Learning?Surgery Helps Babies Missing a Heart Chamber Survive, But Problems LingerAbuse, Injury More Likely When Child is With Male Caregiver: StudyHow to Foster Your Child's ImaginationLow Vitamin D at Birth Linked to Kids' High Blood Pressure RiskHow Do Kids Learn To Turn Off Troublesome Tics?Meet 'Huggable,' the Robot Bear Who's Helping Hospitalized KidsWill Video Games Make Your Kid Obese? Maybe NotChildhood Brain Tumor Survivors Face More StrugglesFDA Expands Cystic Fibrosis Treatment Approval to Children Ages 6 to 12New Drug Combats Leading Cause of DwarfismHow Do Birth Defects Affect Childhood Cancer Risk?FDA Approves Victoza Injection for Children 10 Years and OlderHealth Tip: Preparing Your Child For Sleepaway CampTips for Keeping Your Child Healthy at CampA Simple Way to Help Prevent Child ObesityType 1 Diabetes Might Affect Young Kids' Brain DevelopmentHow to Put Limits on Your Family's Screen TimeChickenpox Vaccine Shields Kids From Shingles, TooWhooping Cough Vaccine Effectiveness Fades With Time: StudyHundreds of Young Kids Drown in Pools Each Year -- Keep Yours SafeWhich Dogs Are More Likely to Bite Your Kids?Health Tip: Preventing Swimmer's EarAHA News: With Summer Vacation Here, How Much Screen Time Is Too Much?Health Tip: Prevent BullyingHealth Tip: Avoid Mouth Injuries in ChildrenKids Still Being Poisoned by Detergent PodsViolent Video Games, Unlocked Guns a Dangerous Combo for KidsWhy Some Kids With Eczema Are at Higher Allergy Risk'Controlled Burns' Better for Kids' Health Than Wildfires: StudyHow Kids Benefit From Doing ChoresAHA News: Report Seeks Answers About Mysterious, Dangerous Heart Disease in KidsKids of Opioid-Using Parents May Be More Likely to Attempt SuicideCholesterol Levels Improving Among U.S. KidsEarlier Bedtimes Help Kids Fight Obesity1 in 5 Kids Don't Strap on Helmets Before Biking
Questions and AnswersLinks
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

Dead End for Treatment of Polio-Like Disorder Striking Kids

HealthDay News
by -- Robert Preidt
Updated: Nov 9th 2018

new article illustration

FRIDAY, Nov. 9, 2018 (HealthDay News) -- The antidepressant fluoxetine (Prozac) is ineffective in treating a rare, polio-like disorder that can cause muscle weakness and paralysis in children, researchers are reporting.

In the United States, there have been 219 possible cases of acute flaccid myelitis (AFM) reported so far this year, and 80 have been confirmed, according to the U.S. Centers for Disease Control and Prevention.

There were 120 confirmed cases in 2014, 22 cases in 2015, 149 cases in 2016 and 33 cases in 2017, the agency said.

The cause of the disorder is unclear, but some patients have been infected with a usually harmless common cold virus called EV-D68.

Researchers have been searching for possible treatments for AFM. Lab tests showed that fluoxetine had antiviral effects against EV-D68, so some experts suggested that the antidepressant might be a possible treatment for the disorder.

In this study, researchers examined data from 56 children -- aged 30 months to 9 years -- who were treated for AFM at 12 U.S. medical centers in 2015 and 2016. More than one dose of fluoxetine was given to 28 patients, while 28 were not given the drug or received just one dose and were considered untreated.

The muscle strength in the children's arms and legs was assessed to determine whether the drug was effective.

After an average follow-up of seven months, the strength scores on a scale of 0-20 fell by 0.2 among the children who received the drug, and improved by 2.5 among those in the untreated group, the findings showed.

The study findings were published in the Nov. 9 online issue of the journal Neurology.

"The lack of an efficacy signal for the treatments for acute flaccid myelitis evaluated in this study emphasizes the need for development and prospective evaluation of more effective treatment and prevention strategies for this potentially devastating condition," study author Dr. Kevin Messacar, of Children's Hospital Colorado in Aurora, said in a journal news release.

Dr. Carlos Pardo-Villamizar, a neurological disease expert with Johns Hopkins University School of Medicine in Baltimore, told HealthDay News, "We need to pay attention to this, because the long-term consequences the children and their parents suffer is immense.

"You can't imagine the amount of suffering these kids have in their lives," he added.

More information

The U.S. Centers for Disease Control and Prevention has more on acute flaccid myelitis.